[S02DA03, antipyrine, The serum concentration of Antipyrine can be increased when it is combined with Givosiran.]
[J01GA01, streptomycin, Givosiran may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Givosiran may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Givosiran may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Givosiran may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Givosiran may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M01AB02, sulindac, The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Givosiran.]
[M01AX04, apazone, The risk or severity of nephrotoxicity can be increased when Azapropazone is combined with Givosiran.]
[N06DA01, tacrine, The serum concentration of Tacrine can be increased when it is combined with Givosiran.]
[L02BA01, tamoxifen, The serum concentration of Tamoxifen can be increased when it is combined with Givosiran.]
[N05CD07, temazepam, Givosiran may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[R03CC03, terbutaline, Givosiran may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Givosiran may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Givosiran may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[N07XX06, tetrabenazine, The serum concentration of Tetrabenazine can be increased when it is combined with Givosiran.]
[S03AA02, tetracycline, Givosiran may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Givosiran.]
[R03DA07, theobromine, The serum concentration of Theobromine can be increased when it is combined with Givosiran.]
[R03DA04, theophylline, The serum concentration of Theophylline can be increased when it is combined with Givosiran.]
[P02CA02, thiabendazole, The serum concentration of Thiabendazole can be increased when it is combined with Givosiran.]
[R06AD03, thiethylperazine, Givosiran may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[N05AC02, thioridazine, The serum concentration of Thioridazine can be increased when it is combined with Givosiran.]
[N05AF04, thiothixene, The serum concentration of Thiothixene can be increased when it is combined with Givosiran.]
[C01BB04, aprindine, The serum concentration of Aprindine can be increased when it is combined with Givosiran.]
[G04BE06, moxisylyte, Givosiran may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Givosiran may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The serum concentration of Ticlopidine can be increased when it is combined with Givosiran.]
[S01ED01, timolol, The serum concentration of Timolol can be increased when it is combined with Givosiran.]
[P01AB02, tinidazole, Givosiran may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Givosiran may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Givosiran may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Givosiran may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Givosiran.]
[N02AX02, tramadol, The serum concentration of Tramadol can be increased when it is combined with Givosiran.]
[N06AX05, trazodone, The serum concentration of Trazodone can be increased when it is combined with Givosiran.]
[C03DB02, triamterene, The serum concentration of Triamterene can be increased when it is combined with Givosiran.]
[N05CD05, triazolam, Givosiran may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[A16AX12, trientine, Givosiran may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The serum concentration of Trifluoperazine can be increased when it is combined with Givosiran.]
[S01AD02, trifluridine, Givosiran may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[A03AA05, trimebutine, Givosiran may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[S01ED04, metipranolol, The serum concentration of Metipranolol can be increased when it is combined with Givosiran.]
[J01EA01, trimethoprim, Givosiran may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Givosiran.]
[N06AX24, vilazodone, The serum concentration of Vilazodone can be increased when it is combined with Givosiran.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Givosiran.]
[L01FX04, ipilimumab, Givosiran may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Givosiran may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[S01AA28, vancomycin, Givosiran may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Givosiran may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Givosiran may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, The serum concentration of Verapamil can be increased when it is combined with Givosiran.]
[N06AX09, viloxazine, Givosiran may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[B03BA01, vitamin B12, Givosiran may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Givosiran.]
[N05AF05, zuclopenthixol, The serum concentration of Zuclopenthixol can be increased when it is combined with Givosiran.]
[M05BA03, pamidronic acid, The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Givosiran.]
[M05BA05, tiludronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Tiludronic acid.]
[B06AC02, icatibant, Givosiran may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Givosiran may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Ibandronate.]
[V03AC02, deferiprone, Givosiran may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Givosiran.]
[L01EJ01, ruxolitinib, Givosiran may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, The serum concentration of Tolterodine can be increased when it is combined with Givosiran.]
[J01DH04, doripenem, Givosiran may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The serum concentration of Atenolol can be increased when it is combined with Givosiran.]
[M01CB03, auranofin, Givosiran may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Givosiran.]
[B03XA04, peginesatide, Givosiran may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Givosiran may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, The serum concentration of Azathioprine can be increased when it is combined with Givosiran.]
[L01BC05, gemcitabine, Givosiran may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Givosiran may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Givosiran.]
[M03BX01, baclofen, Givosiran may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A08AA11, lorcaserin, The serum concentration of Lorcaserin can be increased when it is combined with Givosiran.]
[G04BD12, mirabegron, The serum concentration of Mirabegron can be increased when it is combined with Givosiran.]
[L02BB04, enzalutamide, Givosiran may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[D02BA02, octinoxate, Givosiran may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Givosiran.]
[N04BD02, rasagiline, The serum concentration of Rasagiline can be increased when it is combined with Givosiran.]
[N06DA02, donepezil, The serum concentration of Donepezil can be increased when it is combined with Givosiran.]
[N03AX22, perampanel, The serum concentration of Perampanel can be increased when it is combined with Givosiran.]
[N02CC03, zolmitriptan, The serum concentration of Zolmitriptan can be increased when it is combined with Givosiran.]
[G04BD10, darifenacin, The serum concentration of Darifenacin can be increased when it is combined with Givosiran.]
[V09IX04, fluorodeoxyglucose F18, Givosiran may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The serum concentration of Sildenafil can be increased when it is combined with Givosiran.]
[V08CA11, gadofosveset, Givosiran may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The serum concentration of Ponatinib can be increased when it is combined with Givosiran.]
[A16AX08, teduglutide, Givosiran may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, The serum concentration of Alogliptin can be increased when it is combined with Givosiran.]
[A16AX09, glycerol phenylbutyrate, Givosiran may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Givosiran.]
[N02BA10, benorilate, The risk or severity of nephrotoxicity can be increased when Benorilate is combined with Givosiran.]
[A10BK02, canagliflozin, Givosiran may decrease the excretion rate of Canagliflozin which could result in a higher serum level.]
[A06AX06, tegaserod, The serum concentration of Tegaserod can be increased when it is combined with Givosiran.]
[R02AD01, benzocaine, The serum concentration of Benzocaine can be increased when it is combined with Givosiran.]
[L03AA12, ancestim, Givosiran may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The serum concentration of Celecoxib can be increased when it is combined with Givosiran.]
[N04AC01, benztropine, The serum concentration of Benzatropine can be increased when it is combined with Givosiran.]
[R02AX03, benzydamine, The risk or severity of nephrotoxicity can be increased when Benzydamine is combined with Givosiran.]
[L01EE01, trametinib, Givosiran may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The serum concentration of Benzyl alcohol can be increased when it is combined with Givosiran.]
[V09AX05, florbetapir F-18, Givosiran may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, The serum concentration of Levomilnacipran can be increased when it is combined with Givosiran.]
[C08EA02, bepridil, The serum concentration of Bepridil can be increased when it is combined with Givosiran.]
[A10BJ03, lixisenatide, Givosiran may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Givosiran may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The serum concentration of Ibrutinib can be increased when it is combined with Givosiran.]
[N06AX26, vortioxetine, The serum concentration of Vortioxetine can be increased when it is combined with Givosiran.]
[G03AC08, etonogestrel, Givosiran may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[J05AP08, sofosbuvir, Givosiran may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The serum concentration of Dapagliflozin can be increased when it is combined with Givosiran.]
[C01CA27, droxidopa, Givosiran may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The serum concentration of Acebutolol can be increased when it is combined with Givosiran.]
[N05CH03, tasimelteon, The serum concentration of Tasimelteon can be increased when it is combined with Givosiran.]
[L04AA32, apremilast, The serum concentration of Apremilast can be increased when it is combined with Givosiran.]
[L02BG02, formestane, Givosiran may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S01ED02, betaxolol, The serum concentration of Betaxolol can be increased when it is combined with Givosiran.]
[V03AB34, fomepizole, Givosiran may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Givosiran.]
[V08AA01, diatrizoic acid, Givosiran may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Givosiran may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[A16AX10, eliglustat, The serum concentration of Eliglustat can be increased when it is combined with Givosiran.]
[S01AA15, dihydrostreptomycin, The risk or severity of nephrotoxicity can be increased when Dihydrostreptomycin is combined with Givosiran.]
[L04AX05, pirfenidone, The serum concentration of Pirfenidone can be increased when it is combined with Givosiran.]
[S03AA06, gentamicin, Givosiran may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The serum concentration of Dasabuvir can be increased when it is combined with Givosiran.]
[B01AF03, edoxaban, Givosiran may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The serum concentration of Mirtazapine can be increased when it is combined with Givosiran.]
[N02BE01, acetaminophen, The serum concentration of Acetaminophen can be increased when it is combined with Givosiran.]
[L01DC01, bleomycin, Givosiran may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Givosiran.]
[J05AP06, asunaprevir, The serum concentration of Asunaprevir can be increased when it is combined with Givosiran.]
[N05AX16, brexpiprazole, The serum concentration of Brexpiprazole can be increased when it is combined with Givosiran.]
[M02AA25, aceclofenac, The risk or severity of nephrotoxicity can be increased when Aceclofenac is combined with Givosiran.]
[M01AB11, acemetacin, The risk or severity of nephrotoxicity can be increased when Acemetacin is combined with Givosiran.]
[V03AB37, idarucizumab, Givosiran may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The serum concentration of Trabectedin can be increased when it is combined with Givosiran.]
[J05AF13, tenofovir alafenamide, Givosiran may increase the nephrotoxic activities of Tenofovir alafenamide.]
[L01XG03, ixazomib, Givosiran may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Givosiran may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of nephrotoxicity can be increased when Alminoprofen is combined with Givosiran.]
[N03AX23, brivaracetam, Givosiran may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, The serum concentration of Bromazepam can be increased when it is combined with Givosiran.]
[A02AD05, aluminum magnesium silicate, Givosiran may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Givosiran.]
[S01ED03, levobunolol, The serum concentration of Levobunolol can be increased when it is combined with Givosiran.]
[N01BB01, bupivacaine, The serum concentration of Bupivacaine can be increased when it is combined with Givosiran.]
[C07AA19, bupranolol, The serum concentration of Bupranolol can be increased when it is combined with Givosiran.]
[N07BC01, buprenorphine, The serum concentration of Buprenorphine can be increased when it is combined with Givosiran.]
[N05BE01, buspirone, The serum concentration of Buspirone can be increased when it is combined with Givosiran.]
[L01XX27, arsenic trioxide, Givosiran may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Givosiran may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[S01GX07, azelastine, The serum concentration of Azelastine can be increased when it is combined with Givosiran.]
[L01XK03, rucaparib, The serum concentration of Rucaparib can be increased when it is combined with Givosiran.]
[A07EC04, balsalazide, The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Givosiran.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be increased when it is combined with Givosiran.]
[A06AH05, naldemedine, Givosiran may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The serum concentration of Deutetrabenazine can be increased when it is combined with Givosiran.]
[N02BF02, pregabalin, Givosiran may decrease the excretion rate of Pregabalin which could result in a higher serum level.]
[N06BC01, caffeine, The serum concentration of Caffeine can be increased when it is combined with Givosiran.]
[P01CA02, benznidazole, Givosiran may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Givosiran may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The serum concentration of Tipranavir can be increased when it is combined with Givosiran.]
[N07XX13, valbenazine, The serum concentration of Valbenazine can be increased when it is combined with Givosiran.]
[J01MA23, delafloxacin, Givosiran may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Givosiran may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The serum concentration of Enasidenib can be increased when it is combined with Givosiran.]
[C07AB07, bisoprolol, Givosiran may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[J05AG03, efavirenz, The serum concentration of Efavirenz can be increased when it is combined with Givosiran.]
[J01DC10, cefprozil, The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Givosiran.]
[C07AA17, bopindolol, The serum concentration of Bopindolol can be increased when it is combined with Givosiran.]
[R03BA02, budesonide, Givosiran may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, The risk or severity of nephrotoxicity can be increased when Bumadizone is combined with Givosiran.]
[J05AX18, letermovir, The serum concentration of Letermovir can be increased when it is combined with Givosiran.]
[N01BX04, capsaicin, The serum concentration of Capsaicin can be increased when it is combined with Givosiran.]
[R06AX18, acrivastine, Givosiran may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[L02BB05, apalutamide, Givosiran may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Givosiran may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AG02, carvedilol, The serum concentration of Carvedilol can be increased when it is combined with Givosiran.]
[L04AA37, baricitinib, Givosiran may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, The risk or severity of nephrotoxicity can be increased when Cefepime is combined with Givosiran.]
[J01DD10, cefetamet, The risk or severity of nephrotoxicity can be increased when Cefetamet is combined with Givosiran.]
[J01DD09, cefodizime, The risk or severity of nephrotoxicity can be increased when Cefodizime is combined with Givosiran.]
[J01DC11, ceforanide, The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Givosiran.]
[J01DD13, cefpodoxime, The risk or severity of nephrotoxicity can be increased when Cefpodoxime is combined with Givosiran.]
[L01EC03, encorafenib, The serum concentration of Encorafenib can be increased when it is combined with Givosiran.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Givosiran.]
[J01DD14, ceftibuten, The risk or severity of nephrotoxicity can be increased when Ceftibuten is combined with Givosiran.]
[J01GB14, plazomicin, Givosiran may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The serum concentration of Celiprolol can be increased when it is combined with Givosiran.]
[H01CC03, elagolix, The serum concentration of Elagolix can be increased when it is combined with Givosiran.]
[P01BA07, tafenoquine, The serum concentration of Tafenoquine can be increased when it is combined with Givosiran.]
[A16AX14, migalastat, Givosiran may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The serum concentration of Stiripentol can be increased when it is combined with Givosiran.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be increased when it is combined with Givosiran.]
[S01GX12, cetirizine, Givosiran may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[D08AE05, chloroxylenol, Givosiran may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Givosiran.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be increased when it is combined with Givosiran.]
[N07XX15, inotersen, The risk or severity of nephrotoxicity can be increased when Inotersen is combined with Givosiran.]
[R03BB08, revefenacin, The serum concentration of Revefenacin can be increased when it is combined with Givosiran.]
[L01AD01, carmustine, The serum concentration of Carmustine can be increased when it is combined with Givosiran.]
[A06AX05, prucalopride, Givosiran may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Givosiran.]
[S01ED05, carteolol, The serum concentration of Carteolol can be increased when it is combined with Givosiran.]
[P02BX04, triclabendazole, The serum concentration of Triclabendazole can be increased when it is combined with Givosiran.]
[N06BA14, solriamfetol, Givosiran may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Givosiran may decrease the excretion rate of Clobazam which could result in a higher serum level.]
[J01DC04, cefaclor, The risk or severity of nephrotoxicity can be increased when Cefaclor is combined with Givosiran.]
[J01DB05, cefadroxil, The risk or severity of nephrotoxicity can be increased when Cefadroxil is combined with Givosiran.]
[J01DC03, cefamandole, The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Givosiran.]
[J01DB07, cefatrizine, The risk or severity of nephrotoxicity can be increased when Cefatrizine is combined with Givosiran.]
[J01DB04, cefazolin, The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Givosiran.]
[J01DC09, cefmetazole, The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Givosiran.]
[J01DC06, cefonicid, The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Givosiran.]
[L01EX15, pexidartinib, Givosiran may increase the hepatotoxic activities of Pexidartinib.]
[J01DD12, cefoperazone, The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Givosiran.]
[J01DD01, cefotaxime, The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Givosiran.]
[J01DC05, cefotetan, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Givosiran.]
[J01DC07, cefotiam, The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Givosiran.]
[J01DC01, cefoxitin, The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Givosiran.]
[J01DD03, cefsulodin, The risk or severity of nephrotoxicity can be increased when Cefsulodin is combined with Givosiran.]
[J01DD02, ceftazidime, The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Givosiran.]
[J01DD07, ceftizoxime, The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Givosiran.]
[J01DD04, ceftriaxone, The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Givosiran.]
[S01AA27, cefuroxime, The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Givosiran.]
[M03BX08, cyclobenzaprine, The serum concentration of Cyclobenzaprine can be increased when it is combined with Givosiran.]
[N07XX11, pitolisant, The serum concentration of Pitolisant can be increased when it is combined with Givosiran.]
[N04CX01, istradefylline, The serum concentration of Istradefylline can be increased when it is combined with Givosiran.]
[G04BE04, yohimbine, The serum concentration of Yohimbine can be increased when it is combined with Givosiran.]
[J01XX09, daptomycin, Givosiran may decrease the excretion rate of Daptomycin which could result in a higher serum level.]
[J01DB01, cephalexin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Givosiran.]
[J01DB02, cephaloridine, The risk or severity of nephrotoxicity can be increased when Cefaloridine is combined with Givosiran.]
[J01DB03, cephalothin, The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Givosiran.]
[J01DB08, cephapirin, The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Givosiran.]
[J01DB09, cephradine, The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Givosiran.]
[S01AA13, fusidic acid, The serum concentration of Fusidic acid can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Givosiran may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB02, dexchlorpheniramine, The serum concentration of Dexchlorpheniramine can be increased when it is combined with Givosiran.]
[S01XA12, dexpanthenol, Givosiran may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[J05AE05, amprenavir, The serum concentration of Amprenavir can be increased when it is combined with Givosiran.]
[N02CC07, frovatriptan, The serum concentration of Frovatriptan can be increased when it is combined with Givosiran.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Givosiran.]
[R02AA03, dichlorobenzyl alcohol, Givosiran may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Givosiran may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02AA08, dihydrocodeine, The serum concentration of Dihydrocodeine can be increased when it is combined with Givosiran.]
[N02CC06, eletriptan, The serum concentration of Eletriptan can be increased when it is combined with Givosiran.]
[M01AH02, rofecoxib, The serum concentration of Rofecoxib can be increased when it is combined with Givosiran.]
[C08CA16, clevidipine, The serum concentration of Clevidipine can be increased when it is combined with Givosiran.]
[M01AC04, droxicam, The risk or severity of nephrotoxicity can be increased when Droxicam is combined with Givosiran.]
[V08CA05, mangafodipir, Givosiran may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, The risk or severity of nephrotoxicity can be increased when Dexketoprofen is combined with Givosiran.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Givosiran.]
[P01BA01, chloroquine, The serum concentration of Chloroquine can be increased when it is combined with Givosiran.]
[R06AB04, chlorpheniramine, The serum concentration of Chlorpheniramine can be increased when it is combined with Givosiran.]
[N05AA01, chlorpromazine, The serum concentration of Chlorpromazine can be increased when it is combined with Givosiran.]
[A10BB02, chlorpropamide, Givosiran may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[M03BB03, chlorzoxazone, The serum concentration of Chlorzoxazone can be increased when it is combined with Givosiran.]
[N02BA07, ethenzamide, The risk or severity of nephrotoxicity can be increased when Ethenzamide is combined with Givosiran.]
[M01AB08, etodolac, The risk or severity of nephrotoxicity can be increased when Etodolac is combined with Givosiran.]
[M02AA06, etofenamate, The risk or severity of nephrotoxicity can be increased when Etofenamate is combined with Givosiran.]
[M01AX25, chondroitin sulfates, Givosiran may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[M01AE05, fenbufen, The risk or severity of nephrotoxicity can be increased when Fenbufen is combined with Givosiran.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be increased when it is combined with Givosiran.]
[C01CA19, fenoldopam, Givosiran may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Givosiran may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Givosiran may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Givosiran may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The serum concentration of Formoterol can be increased when it is combined with Givosiran.]
[A02BA01, cimetidine, Givosiran may decrease the excretion rate of Cimetidine which could result in a higher serum level.]
[V08CA04, gadoteridol, Givosiran may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[N07CA02, cinnarizine, The serum concentration of Cinnarizine can be increased when it is combined with Givosiran.]
[S03AA07, ciprofloxacin, Givosiran may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.]
[L01XA01, cisplatin, Givosiran may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The serum concentration of Citalopram can be increased when it is combined with Givosiran.]
[P01CA03, fexinidazole, The serum concentration of Fexinidazole can be increased when it is combined with Givosiran.]
[M01AG01, mefenamic acid, The serum concentration of Mefenamic acid can be increased when it is combined with Givosiran.]
[N01BB10, levobupivacaine, The serum concentration of Levobupivacaine can be increased when it is combined with Givosiran.]
[N06AA04, clomipramine, The serum concentration of Clomipramine can be increased when it is combined with Givosiran.]
[N03AE01, clonazepam, Givosiran may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The serum concentration of Clonidine can be increased when it is combined with Givosiran.]
[J05AH02, oseltamivir, Givosiran may decrease the excretion rate of Oseltamivir which could result in a higher serum level.]
[A04AA01, ondansetron, The serum concentration of Ondansetron can be increased when it is combined with Givosiran.]
[N05AH02, clozapine, The serum concentration of Clozapine can be increased when it is combined with Givosiran.]
[J01GB12, arbekacin, Givosiran may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[M01AX13, proquazone, The risk or severity of nephrotoxicity can be increased when Proquazone is combined with Givosiran.]
[R05DA04, codeine, The serum concentration of Codeine can be increased when it is combined with Givosiran.]
[M04AC01, colchicine, Givosiran may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Givosiran may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, The risk or severity of nephrotoxicity can be increased when Cefpirome is combined with Givosiran.]
[L04AA13, leflunomide, The serum concentration of Leflunomide can be increased when it is combined with Givosiran.]
[A04AA03, tropisetron, Givosiran may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, The serum concentration of Nateglinide can be increased when it is combined with Givosiran.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of nephrotoxicity can be increased when Imidazole salicylate is combined with Givosiran.]
[R03BA08, ciclesonide, The serum concentration of Ciclesonide can be increased when it is combined with Givosiran.]
[B01AC10, indobufen, The risk or severity of nephrotoxicity can be increased when Indobufen is combined with Givosiran.]
[J05AB14, valganciclovir, Givosiran may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Givosiran may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Givosiran may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Givosiran may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Givosiran may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Givosiran may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Givosiran.]
[N02CC05, almotriptan, The serum concentration of Almotriptan can be increased when it is combined with Givosiran.]
[M01AH04, parecoxib, The risk or severity of nephrotoxicity can be increased when Parecoxib is combined with Givosiran.]
[S01AD03, acyclovir, The serum concentration of Acyclovir can be increased when it is combined with Givosiran.]
[N05BA10, ketazolam, Givosiran may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of nephrotoxicity can be increased when Kebuzone is combined with Givosiran.]
[L01EA01, imatinib, The serum concentration of Imatinib can be increased when it is combined with Givosiran.]
[N03AX09, lamotrigine, Givosiran may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[N07BC04, lofexidine, The serum concentration of Lofexidine can be increased when it is combined with Givosiran.]
[S01AE04, lomefloxacin, The serum concentration of Lomefloxacin can be increased when it is combined with Givosiran.]
[M01AB09, lonazolac, The risk or severity of nephrotoxicity can be increased when Lonazolac is combined with Givosiran.]
[M02AA31, loxoprofen, The risk or severity of nephrotoxicity can be increased when Loxoprofen is combined with Givosiran.]
[J01DC08, loracarbef, The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Givosiran.]
[C09AA03, lisinopril, Givosiran may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Givosiran may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C07AA14, mepindolol, The serum concentration of Mepindolol can be increased when it is combined with Givosiran.]
[R06AD07, mequitazine, The serum concentration of Mequitazine can be increased when it is combined with Givosiran.]
[J01DH02, meropenem, Givosiran may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[N05AD03, metylperon, Givosiran may decrease the excretion rate of Melperone which could result in a higher serum level.]
[J05AF07, tenofovir disoproxil, Givosiran may increase the nephrotoxic activities of Tenofovir disoproxil.]
[N06AX07, minaprine, The serum concentration of Minaprine can be increased when it is combined with Givosiran.]
[S01XA18, cyclosporine, The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Givosiran.]
[N06AG02, moclobemide, The serum concentration of Moclobemide can be increased when it is combined with Givosiran.]
[M02AA02, mofebutazone, The risk or severity of nephrotoxicity can be increased when Mofebutazone is combined with Givosiran.]
[M01AX22, morniflumate, The risk or severity of nephrotoxicity can be increased when Morniflumate is combined with Givosiran.]
[J05AF10, entecavir, The serum concentration of Entecavir can be increased when it is combined with Givosiran.]
[M01AH05, etoricoxib, The serum concentration of Etoricoxib can be increased when it is combined with Givosiran.]
[L01AX04, dacarbazine, The serum concentration of Dacarbazine can be increased when it is combined with Givosiran.]
[C02CC04, debrisoquin, The serum concentration of Debrisoquine can be increased when it is combined with Givosiran.]
[M01AX01, nabumetone, The serum concentration of Nabumetone can be increased when it is combined with Givosiran.]
[N07BB05, nalmefene, Givosiran may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, The serum concentration of Nebivolol can be increased when it is combined with Givosiran.]
[S01GX04, nedocromil, Givosiran may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, The serum concentration of Nefazodone can be increased when it is combined with Givosiran.]
[C01DX16, nicorandil, Givosiran may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Givosiran may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be increased when it is combined with Givosiran.]
[B01AX05, fondaparinux, Givosiran may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[N06AB10, escitalopram, The serum concentration of Escitalopram can be increased when it is combined with Givosiran.]
[G04BD08, solifenacin, The serum concentration of Solifenacin can be increased when it is combined with Givosiran.]
[A07EC03, olsalazine, The risk or severity of nephrotoxicity can be increased when Olsalazine is combined with Givosiran.]
[N06AA01, desipramine, The serum concentration of Desipramine can be increased when it is combined with Givosiran.]
[H01BA02, desmopressin, Givosiran may decrease the excretion rate of Desmopressin which could result in a higher serum level.]
[V04CH02, indigo carmine, Givosiran may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Givosiran may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Givosiran.]
[A08AA04, dexfenfluramine, The serum concentration of Dexfenfluramine can be increased when it is combined with Givosiran.]
[L01EB01, gefitinib, The serum concentration of Gefitinib can be increased when it is combined with Givosiran.]
[N06BA02, dextroamphetamine, The serum concentration of Amphetamine can be increased when it is combined with Givosiran.]
[R05DA09, dextromethorphan, The serum concentration of Dextromethorphan can be increased when it is combined with Givosiran.]
[N06AB05, paroxetine, The serum concentration of Paroxetine can be increased when it is combined with Givosiran.]
[B01AC04, clopidogrel, The serum concentration of Clopidogrel can be increased when it is combined with Givosiran.]
[C01DA05, pentaerythritol tetranitrate, Givosiran may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be increased when it is combined with Givosiran.]
[P03AC04, permethrin, Givosiran may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Givosiran may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R05DA08, pholcodine, Givosiran may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Clodronic acid.]
[S01BC03, diclofenac, The serum concentration of Diclofenac can be increased when it is combined with Givosiran.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Givosiran is combined with Foscarnet.]
[A03AA07, dicyclomine, Givosiran may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Givosiran may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be increased when it is combined with Givosiran.]
[C08CA03, isradipine, Givosiran may decrease the excretion rate of Isradipine which could result in a higher serum level.]
[D07XC04, diflucortolone, Givosiran may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of nephrotoxicity can be increased when Diflunisal is combined with Givosiran.]
[C01AA05, digoxin, Givosiran may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, The serum concentration of Dihydralazine can be increased when it is combined with Givosiran.]
[N02AA03, hydromorphone, Givosiran may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Givosiran may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Givosiran.]
[H03BC01, potassium perchlorate, Givosiran may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Givosiran may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[C08DB01, diltiazem, The serum concentration of Diltiazem can be increased when it is combined with Givosiran.]
[V03AB09, dimercaprol, Givosiran may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Givosiran may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be increased when it is combined with Givosiran.]
[N02BB04, propyphenazone, The risk or severity of nephrotoxicity can be increased when Propyphenazone is combined with Givosiran.]
[M01AB14, proglumetacin, The risk or severity of nephrotoxicity can be increased when Proglumetacin is combined with Givosiran.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be increased when it is combined with Givosiran.]
[R06AA02, diphenhydramine, The serum concentration of Diphenhydramine can be increased when it is combined with Givosiran.]
[N05AL04, remoxipride, The serum concentration of Remoxipride can be increased when it is combined with Givosiran.]
[S01AX06, resorcinol, Givosiran may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The serum concentration of Disopyramide can be increased when it is combined with Givosiran.]
[N07XX02, riluzole, The serum concentration of Riluzole can be increased when it is combined with Givosiran.]
[N05AX08, risperidone, The serum concentration of Risperidone can be increased when it is combined with Givosiran.]
[R06AE09, levocetirizine, Givosiran may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The serum concentration of Ropivacaine can be increased when it is combined with Givosiran.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Givosiran.]
[G04BE08, tadalafil, Givosiran may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Givosiran.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Givosiran.]
[N02BA06, salsalate, The risk or severity of nephrotoxicity can be increased when Salsalate is combined with Givosiran.]
[H05BA01, salmon calcitonin, Givosiran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.]
[C01CA07, dobutamine, Givosiran may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[A03FA03, domperidone, The serum concentration of Domperidone can be increased when it is combined with Givosiran.]
[C01CA04, dopamine, Givosiran may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA16, dothiepin, The serum concentration of Dosulepin can be increased when it is combined with Givosiran.]
[N06AA12, doxepin, The serum concentration of Doxepin can be increased when it is combined with Givosiran.]
[J01AA02, doxycycline, Givosiran may decrease the excretion rate of Doxycycline which could result in a higher serum level.]
[N06AB06, sertraline, The serum concentration of Sertraline can be increased when it is combined with Givosiran.]
[A08AA10, sibutramine, Givosiran may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The serum concentration of Simvastatin can be increased when it is combined with Givosiran.]
[A12CA02, sodium sulfate, Givosiran may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Givosiran may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Givosiran may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Givosiran may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Givosiran.]
[J01MA05, temafloxacin, The serum concentration of Temafloxacin can be increased when it is combined with Givosiran.]
[L01AX03, temozolomide, Givosiran may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Givosiran.]
[D01BA02, terbinafine, The serum concentration of Terbinafine can be increased when it is combined with Givosiran.]
[C07AA16, tertatolol, The serum concentration of Tertatolol can be increased when it is combined with Givosiran.]
[M01AG02, tolfenamic acid, The risk or severity of nephrotoxicity can be increased when Tolfenamic acid is combined with Givosiran.]
[N06AG03, toloxatone, Givosiran may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, The serum concentration of Atomoxetine can be increased when it is combined with Givosiran.]
[N03AX11, topiramate, Givosiran may decrease the excretion rate of Topiramate which could result in a higher serum level.]
[N05CC01, chloral hydrate, Givosiran may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[S01GX10, epinastine, The serum concentration of Epinastine can be increased when it is combined with Givosiran.]
[N06AX16, venlafaxine, The serum concentration of Venlafaxine can be increased when it is combined with Givosiran.]
[N05CF02, zolpidem, The serum concentration of Zolpidem can be increased when it is combined with Givosiran.]
[M01AB04, zomepirac, The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Givosiran.]
[N03AX15, zonisamide, Givosiran may decrease the excretion rate of Zonisamide which could result in a higher serum level.]
[N05AX11, zotepine, The serum concentration of Zotepine can be increased when it is combined with Givosiran.]
[L01XA02, carboplatin, The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Givosiran.]
[C02AC02, guanfacine, Givosiran may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[L03AX05, pidotimod, Givosiran may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Givosiran may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Givosiran may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[H05BX01, cinacalcet, The serum concentration of Cinacalcet can be increased when it is combined with Givosiran.]
[G03CA03, estradiol, The serum concentration of Estradiol can be increased when it is combined with Givosiran.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Givosiran.]
[G03CC04, estrone, The serum concentration of Estrone can be increased when it is combined with Givosiran.]
[J04AK02, ethambutol, Givosiran may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[C10AA04, fluvastatin, The serum concentration of Fluvastatin can be increased when it is combined with Givosiran.]
[V08CA03, gadodiamide, Givosiran may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The serum concentration of Ethinylestradiol can be increased when it is combined with Givosiran.]
[C01BD05, ibutilide, Givosiran may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[M01AC06, meloxicam, The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Givosiran.]
[S01XA06, ethylmorphine, The serum concentration of Ethylmorphine can be increased when it is combined with Givosiran.]
[N01AX07, etomidate, Givosiran may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Givosiran.]
[N05AE03, sertindole, The serum concentration of Sertindole can be increased when it is combined with Givosiran.]
[L04AD02, tacrolimus, The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Givosiran.]
[R06AX11, astemizole, The serum concentration of Astemizole can be increased when it is combined with Givosiran.]
[R06AX12, terfenadine, The serum concentration of Terfenadine can be increased when it is combined with Givosiran.]
[P01AX07, trimetrexate, Givosiran may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Givosiran may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The serum concentration of Fluvoxamine can be increased when it is combined with Givosiran.]
[C01BB03, tocainide, The serum concentration of Tocainide can be increased when it is combined with Givosiran.]
[C01BC08, encainide, The serum concentration of Encainide can be increased when it is combined with Givosiran.]
[L02AE02, leuprolide, Givosiran may decrease the excretion rate of Leuprolide which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Givosiran may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Givosiran may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Givosiran may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A16AA01, levocarnitine, Givosiran may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[P02CA03, albendazole, The serum concentration of Albendazole can be increased when it is combined with Givosiran.]
[N03AX26, fenfluramine, The serum concentration of Fenfluramine can be increased when it is combined with Givosiran.]
[M01AE04, fenoprofen, The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Givosiran.]
[N02AB03, fentanyl, Givosiran may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Givosiran may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, Givosiran may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07AX03, cevimeline, The serum concentration of Cevimeline can be increased when it is combined with Givosiran.]
[G04BD02, flavoxate, Givosiran may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The serum concentration of Flecainide can be increased when it is combined with Givosiran.]
[N02BG04, floctafenine, The risk or severity of nephrotoxicity can be increased when Floctafenine is combined with Givosiran.]
[J02AC01, fluconazole, Givosiran may decrease the excretion rate of Fluconazole which could result in a higher serum level.]
[J02AX01, flucytosine, Givosiran may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Givosiran may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The serum concentration of Flunarizine can be increased when it is combined with Givosiran.]
[V03AZ01, ethanol, The serum concentration of Ethanol can be increased when it is combined with Givosiran.]
[L01BC09, floxuridine, Givosiran may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[L01BC02, fluorouracil, The serum concentration of Fluorouracil can be increased when it is combined with Givosiran.]
[N06AB03, fluoxetine, The serum concentration of Fluoxetine can be increased when it is combined with Givosiran.]
[N05CD01, flurazepam, Givosiran may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of nephrotoxicity can be increased when Flurbiprofen is combined with Givosiran.]
[L02BB01, flutamide, The serum concentration of Flutamide can be increased when it is combined with Givosiran.]
[V04CX02, folic acid, Givosiran may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Givosiran may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Givosiran.]
[L01BC03, tegafur, The serum concentration of Tegafur can be increased when it is combined with Givosiran.]
[C03CA01, furosemide, The risk or severity of nephrotoxicity can be increased when Furosemide is combined with Givosiran.]
[M05BA04, alendronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Alendronic acid.]
[N05CF04, eszopiclone, Givosiran may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[N06DA04, galantamine, The serum concentration of Galantamine can be increased when it is combined with Givosiran.]
[S01AD09, ganciclovir, Givosiran may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, Givosiran may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Givosiran may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Givosiran.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be increased when it is combined with Givosiran.]
[A10BB07, glipizide, Givosiran may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Givosiran may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[C02CA04, doxazosin, The serum concentration of Doxazosin can be increased when it is combined with Givosiran.]
[L01EX02, sorafenib, The serum concentration of Sorafenib can be increased when it is combined with Givosiran.]
[C07AB09, esmolol, The serum concentration of Esmolol can be increased when it is combined with Givosiran.]
[M01CB04, aurothioglucose, Givosiran may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Givosiran may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Givosiran may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01EX01, guanethidine, Givosiran may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Givosiran may decrease the excretion rate of Goserelin which could result in a higher serum level.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Givosiran.]
[N05AH04, quetiapine, The serum concentration of Quetiapine can be increased when it is combined with Givosiran.]
[N06BX13, idebenone, Givosiran may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Givosiran may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[G03DC01, allylestrenol, Givosiran may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Givosiran.]
[C01CE02, milrinone, Givosiran may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[J05AG01, nevirapine, The serum concentration of Nevirapine can be increased when it is combined with Givosiran.]
[M02AA26, nimesulide, The risk or severity of nephrotoxicity can be increased when Nimesulide is combined with Givosiran.]
[C09AA04, perindopril, Givosiran may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Givosiran may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Givosiran.]
[R05DA03, hydrocodone, The serum concentration of Hydrocodone can be increased when it is combined with Givosiran.]
[B05XA17, potassium acetate, Givosiran may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[V03AB33, hydroxocobalamin, Givosiran may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, Givosiran may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The serum concentration of Hydroxychloroquine can be increased when it is combined with Givosiran.]
[B05AA07, hetastarch, Givosiran may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Risedronic acid.]
[R02AX02, ibuprofen, The risk or severity of nephrotoxicity can be increased when Ibuprofen is combined with Givosiran.]
[B05XA08, sodium acetate, Givosiran may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The serum concentration of Idarubicin can be increased when it is combined with Givosiran.]
[L01AA06, ifosfamide, Givosiran may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Givosiran.]
[R01AD07, tixocortol, Givosiran may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The serum concentration of Tizanidine can be increased when it is combined with Givosiran.]
[L01CE01, topotecan, Givosiran may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Givosiran may decrease the excretion rate of Indapamide which could result in a higher serum level.]
[S01BC01, indomethacin, The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Givosiran.]
[A11HA07, inositol, Givosiran may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Givosiran may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Givosiran may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, Givosiran may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Givosiran may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, The serum concentration of Ramelteon can be increased when it is combined with Givosiran.]
[L01XX35, anagrelide, The serum concentration of Anagrelide can be increased when it is combined with Givosiran.]
[C07AA01, alprenolol, The serum concentration of Alprenolol can be increased when it is combined with Givosiran.]
[V03AB01, ipecac, The serum concentration of Ipecac can be increased when it is combined with Givosiran.]
[J05AB13, penciclovir, The serum concentration of Penciclovir can be increased when it is combined with Givosiran.]
[J04AC01, isoniazid, Givosiran may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Givosiran may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Givosiran may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, Givosiran may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[S01AA24, kanamycin, Givosiran may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Givosiran may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Givosiran may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[N05AH03, olanzapine, The serum concentration of Olanzapine can be increased when it is combined with Givosiran.]
[M02AA10, ketoprofen, The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Givosiran.]
[N04BC09, rotigotine, The serum concentration of Rotigotine can be increased when it is combined with Givosiran.]
[M01AE11, tiaprofenic acid, The risk or severity of nephrotoxicity can be increased when Tiaprofenic acid is combined with Givosiran.]
[C07AG01, labetalol, The serum concentration of Labetalol can be increased when it is combined with Givosiran.]
[N04BB01, amantadine, Givosiran may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AX03, lubiprostone, Givosiran may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Givosiran.]
[S02DA01, lidocaine, The serum concentration of Lidocaine can be increased when it is combined with Givosiran.]
[S01AA21, amikacin, Givosiran may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N02CA07, lisuride, The serum concentration of Lisuride can be increased when it is combined with Givosiran.]
[N05BA06, lorazepam, Givosiran may decrease the excretion rate of Lorazepam which could result in a higher serum level.]
[B05XA11, magnesium chloride, Givosiran may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Givosiran may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Givosiran may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Givosiran.]
[N06AA21, maprotiline, The serum concentration of Maprotiline can be increased when it is combined with Givosiran.]
[C02BB01, mecamylamine, Givosiran may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[R06AE05, meclizine, The serum concentration of Meclizine can be increased when it is combined with Givosiran.]
[M02AA18, meclofenamic acid, The risk or severity of nephrotoxicity can be increased when Meclofenamic acid is combined with Givosiran.]
[N05CH01, melatonin, The serum concentration of Melatonin can be increased when it is combined with Givosiran.]
[N06DX01, memantine, Givosiran may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Givosiran may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[N03AB04, mephenytoin, The serum concentration of Mephenytoin can be increased when it is combined with Givosiran.]
[N01BB03, mepivacaine, Givosiran may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Givosiran may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Givosiran may decrease the excretion rate of Mersalyl which could result in a higher serum level.]
[N05AC03, mesoridazine, The serum concentration of Mesoridazine can be increased when it is combined with Givosiran.]
[N05AX13, paliperidone, The serum concentration of Paliperidone can be increased when it is combined with Givosiran.]
[A10BA02, metformin, Givosiran may decrease the excretion rate of Metformin which could result in a higher serum level.]
[A04AA04, dolasetron, The serum concentration of Dolasetron can be increased when it is combined with Givosiran.]
[N07BC02, methadone, The serum concentration of Methadone can be increased when it is combined with Givosiran.]
[N06BA03, methamphetamine, The serum concentration of Metamfetamine can be increased when it is combined with Givosiran.]
[J05AF05, lamivudine, Givosiran may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BB02, methimazole, Givosiran may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, The serum concentration of Pemetrexed can be increased when it is combined with Givosiran.]
[A11HA02, pyridoxine, Givosiran may decrease the excretion rate of Pyridoxine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of nephrotoxicity can be increased when Methotrexate is combined with Givosiran.]
[N05AA02, methotrimeprazine, The serum concentration of Methotrimeprazine can be increased when it is combined with Givosiran.]
[D05BA02, methoxsalen, Givosiran may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[N02BG09, methoxyflurane, The serum concentration of Methoxyflurane can be increased when it is combined with Givosiran.]
[C02AB01, methyldopa, Givosiran may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, The serum concentration of Methylene blue can be increased when it is combined with Givosiran.]
[R03DA05, aminophylline, The serum concentration of Aminophylline can be increased when it is combined with Givosiran.]
[G03EK01, methyltestosterone, Givosiran may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The serum concentration of Metoclopramide can be increased when it is combined with Givosiran.]
[C03BA08, metolazone, Givosiran may decrease the excretion rate of Metolazone which could result in a higher serum level.]
[C07AB02, metoprolol, The serum concentration of Metoprolol can be increased when it is combined with Givosiran.]
[V04CD01, metyrapone, Givosiran may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, The serum concentration of Mexiletine can be increased when it is combined with Givosiran.]
[N06AX03, mianserin, The serum concentration of Mianserin can be increased when it is combined with Givosiran.]
[N02BB03, aminopyrine, The serum concentration of Aminophenazone can be increased when it is combined with Givosiran.]
[N05CD08, midazolam, Givosiran may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[J05AH01, zanamivir, Givosiran may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[N06BA12, lisdexamfetamine, The serum concentration of Lisdexamfetamine can be increased when it is combined with Givosiran.]
[L03AC01, aldesleukin, Givosiran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.]
[N06AA09, amitriptyline, The serum concentration of Amitriptyline can be increased when it is combined with Givosiran.]
[A04AA05, palonosetron, The serum concentration of Palonosetron can be increased when it is combined with Givosiran.]
[J01DD06, moxalactam, The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Givosiran.]
[L04AB05, certolizumab pegol, Givosiran may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[B02BX05, eltrombopag, The serum concentration of Eltrombopag can be increased when it is combined with Givosiran.]
[G04BA01, ammonium chloride, Givosiran may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Givosiran.]
[L04AA06, mycophenolic acid, Givosiran may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N06AA17, amoxapine, The serum concentration of Amoxapine can be increased when it is combined with Givosiran.]
[C07AA12, nadolol, The serum concentration of Nadolol can be increased when it is combined with Givosiran.]
[J01CA04, amoxicillin, Givosiran may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The serum concentration of Ropinirole can be increased when it is combined with Givosiran.]
[V03AB15, naloxone, Givosiran may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, The serum concentration of Amphetamine can be increased when it is combined with Givosiran.]
[M02AA12, naproxen, The serum concentration of Naproxen can be increased when it is combined with Givosiran.]
[N06AX21, duloxetine, The serum concentration of Duloxetine can be increased when it is combined with Givosiran.]
[N04BX01, tolcapone, Givosiran may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[S03AA01, neomycin, The risk or severity of nephrotoxicity can be increased when Givosiran is combined with Neomycin.]
[B01AC17, tirofiban, Givosiran may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, The serum concentration of Iloperidone can be increased when it is combined with Givosiran.]
[J02AA01, amphotericin B, The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Givosiran.]
[S01AA19, ampicillin, Givosiran may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Givosiran may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Givosiran may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Givosiran may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Givosiran.]
[C01CE01, inamrinone, Givosiran may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C04AE02, nicergoline, The serum concentration of Nicergoline can be increased when it is combined with Givosiran.]
[C08CA05, nifedipine, The serum concentration of Nifedipine can be increased when it is combined with Givosiran.]
[M02AA17, niflumic acid, The risk or severity of nephrotoxicity can be increased when Niflumic acid is combined with Givosiran.]
[C08CA07, nisoldipine, Givosiran may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Givosiran may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Givosiran may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Givosiran may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Givosiran may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Givosiran may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Givosiran.]
[N02AA02, opium, The serum concentration of Opium can be increased when it is combined with Givosiran.]
[G04CA02, tamsulosin, The serum concentration of Tamsulosin can be increased when it is combined with Givosiran.]
[M05BA08, zoledronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Zoledronic acid.]
[J01CF04, oxacillin, Givosiran may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Givosiran may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, The serum concentration of Oxprenolol can be increased when it is combined with Givosiran.]
[N02AA05, oxycodone, The serum concentration of Oxycodone can be increased when it is combined with Givosiran.]
[N02AA11, oxymorphone, The serum concentration of Oxymorphone can be increased when it is combined with Givosiran.]
[S01BC02, oxyphenbutazone, The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Givosiran.]
[N05AH05, asenapine, The serum concentration of Asenapine can be increased when it is combined with Givosiran.]
[J04AB30, capreomycin, Givosiran may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, The risk or severity of nephrotoxicity can be increased when Paromomycin is combined with Givosiran.]
[G04BD11, fesoterodine, The serum concentration of Fesoterodine can be increased when it is combined with Givosiran.]
[C07AA23, penbutolol, The serum concentration of Penbutolol can be increased when it is combined with Givosiran.]
[J01CE09, penicillin G procaine, Givosiran may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Givosiran may decrease the excretion rate of Pentobarbital which could result in a higher serum level.]
[L01XX08, pentostatin, Givosiran may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, The serum concentration of Pentoxifylline can be increased when it is combined with Givosiran.]
[C08EX02, perhexiline, The serum concentration of Perhexiline can be increased when it is combined with Givosiran.]
[N05AB03, perphenazine, The serum concentration of Perphenazine can be increased when it is combined with Givosiran.]
[N02BE03, phenacetin, The serum concentration of Phenacetin can be increased when it is combined with Givosiran.]
[G04BX06, phenazopyridine, The risk or severity of nephrotoxicity can be increased when Phenazopyridine is combined with Givosiran.]
[N06AF03, phenelzine, Givosiran may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[A10BA01, phenformin, The serum concentration of Phenformin can be increased when it is combined with Givosiran.]
[V03AB36, phentolamine, Givosiran may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Givosiran.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Givosiran.]
[S01AE05, levofloxacin, Givosiran may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Givosiran may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Givosiran.]
[N05AG02, pimozide, The serum concentration of Pimozide can be increased when it is combined with Givosiran.]
[C07AA03, pindolol, The serum concentration of Pindolol can be increased when it is combined with Givosiran.]
[J01CA12, piperacillin, Givosiran may decrease the excretion rate of Piperacillin which could result in a higher serum level.]
[P02CB01, piperazine, The serum concentration of Piperazine can be increased when it is combined with Givosiran.]
[N05AC04, pipothiazine, The serum concentration of Pipotiazine can be increased when it is combined with Givosiran.]
[N06BX03, piracetam, Givosiran may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The risk or severity of nephrotoxicity can be increased when Piroxicam is combined with Givosiran.]
[J01DD16, cefditoren, The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Givosiran.]
[J01MA11, grepafloxacin, The serum concentration of Grepafloxacin can be increased when it is combined with Givosiran.]
[J05AG02, delavirdine, The serum concentration of Delavirdine can be increased when it is combined with Givosiran.]
[A10BG02, rosiglitazone, Givosiran may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[A03AE01, alosetron, The serum concentration of Alosetron can be increased when it is combined with Givosiran.]
[S03AA03, polymyxin B, The risk or severity of adverse effects can be increased when Givosiran is combined with Polymyxin B.]
[J05AE03, ritonavir, The serum concentration of Ritonavir can be increased when it is combined with Givosiran.]
[A10BH03, saxagliptin, Givosiran may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Givosiran may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[C07AB01, practolol, The serum concentration of Practolol can be increased when it is combined with Givosiran.]
[P02BA01, praziquantel, The serum concentration of Praziquantel can be increased when it is combined with Givosiran.]
[H02AB07, prednisone, Givosiran may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[P01BA03, primaquine, The serum concentration of Primaquine can be increased when it is combined with Givosiran.]
[M04AB01, probenecid, Givosiran may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, The serum concentration of Procainamide can be increased when it is combined with Givosiran.]
[C10AB05, fenofibrate, Givosiran may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AB04, prochlorperazine, The serum concentration of Prochlorperazine can be increased when it is combined with Givosiran.]
[G03DA04, progesterone, The serum concentration of Progesterone can be increased when it is combined with Givosiran.]
[N05AA03, promazine, The serum concentration of Promazine can be increased when it is combined with Givosiran.]
[R06AD02, promethazine, The serum concentration of Promethazine can be increased when it is combined with Givosiran.]
[C01BC03, propafenone, The serum concentration of Propafenone can be increased when it is combined with Givosiran.]
[A03AB05, propantheline, Givosiran may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N02AC04, propoxyphene, The serum concentration of Dextropropoxyphene can be increased when it is combined with Givosiran.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Givosiran.]
[N02CC04, rizatriptan, Givosiran may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Givosiran may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N05AX12, aripiprazole, The serum concentration of Aripiprazole can be increased when it is combined with Givosiran.]
[N07XX07, dalfampridine, Givosiran may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Givosiran may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Givosiran may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[C01BA01, quinidine, Givosiran may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The serum concentration of Quinine can be increased when it is combined with Givosiran.]
[A02BA02, ranitidine, The serum concentration of Ranitidine can be increased when it is combined with Givosiran.]
[C02AA02, reserpine, Givosiran may decrease the excretion rate of Reserpine which could result in a higher serum level.]
[J05AP01, ribavirin, Givosiran may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[N02BA05, salicylamide, The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Givosiran.]
[A07EC01, sulfasalazine, The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Givosiran.]
[S01BC08, salicylic acid, The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Givosiran.]
[N05CA06, secobarbital, Givosiran may decrease the excretion rate of Secobarbital which could result in a higher serum level.]
[N04BD01, selegiline, The serum concentration of Selegiline can be increased when it is combined with Givosiran.]
[J01GB08, sisomicin, Givosiran may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Givosiran may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Givosiran may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The serum concentration of Sotalol can be increased when it is combined with Givosiran.]
[N02BA03, choline salicylate, Givosiran may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Givosiran may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Givosiran may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Givosiran may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M05BA01, etidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Etidronic acid.]
[D10AX03, azelaic acid, Givosiran may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
